查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1420114

頭孢菌素藥物的全球市場：按世代、給藥途徑、應用、地區和國家分類的分析、市場考察和預測

Global Cephalosporin Drug Market : Analysis by Generation, Route of Administration, Application, By Region, By Country: Market Insights and Forecast
出版日期: | 出版商: Azoth Analytics | 英文 260 Pages | 訂單完成後即時交付

價格

全球頭孢菌素藥物市場規模預計將從2022年的132.7億美元增加到2029年終的219億美元。全球頭孢菌素藥物市場的有利成長要素是細菌感染疾病的流行、抗生素抗藥性模式、監管核准和新製劑的推出。預計2024-2029年期間，全球頭孢菌素藥物市場將以7.5%的年複合成長率擴張。製藥公司致力於開發新一代頭孢菌素製劑來對抗抗藥性細菌。新一代藥物的開發、聯合治療、緩釋性和擴大適應症都促進了頭孢菌素藥物的發展。

全球細菌感染疾病（包括呼吸道感染疾病、尿道感染、皮膚軟組織感染疾病和腹腔內感染疾病）的高盛行率和不斷增加的盛行率是一個重要的促進因素。頭孢菌素是治療這些感染疾病的常用抗生素，推動了對頭孢菌素藥物的需求。

疫情期間，由於封鎖、運輸限制和工廠關閉，全球藥品供應鏈面臨中斷。這些中斷影響了藥物（包括頭孢菌素藥物）的生產、分銷和供應。然而，已採取行動減輕影響並確保基本藥物的持續供應。這場大流行也擾亂了進行的臨床試驗，並推遲了新臨床試驗的開始，包括與頭孢菌素藥物開發相關的臨床試驗。這種中斷可能影響了新頭孢菌素的引進和擴大其使用的時間表。

進行的研究和開發開發先進的藥物輸送系統，包括吸入製劑和新型呼吸裝置。這些技術目的是增強頭孢菌素藥物向呼吸道的靶向輸送，提高療效並最大限度地減少副作用。

緩釋性目的是較長時間內逐漸釋放頭孢菌素製劑，減少給藥頻率。這提高了病人用藥醫囑遵從性和便利性。藥物控制釋放技術的進步，例如控釋機制，可以確保治療效果的持久性，並降低與藥物快速釋放相關的副作用的風險。

藥品製造中的連續製造流程在效率、成本效益和品管方面具有優勢。將這些製程應用於頭孢菌素生產將導致生產流程更加精簡和可擴展。智慧包裝還結合了無線射頻識別（RFID）和 QR 碼等技術來監控藥品儲存、追蹤有效期並提高整體產品完整性。這確保了頭孢菌素藥物在整個生命週期中的品質和穩定性。

本報告研究了全球頭孢菌素藥物市場，並提供包括市場規模和預測、區域和細分市場分析以及主要趨勢和機會在內的資訊。

目錄

第1章 市集背景

  • 產品範圍和產品前景
  • 執行摘要
  • 調查方法

第2章 戰略建議

第3章 全球頭孢菌素藥物市場：實績與預測（2019-2029）

  • 宏觀經濟因素對全球頭孢菌素類藥品市場的影響分析
  • 管道場景
  • 全球與抗菌素抗藥性相關的死亡
  • 流行病學：全球感染疾病流行情況
  • 流行病學：全球感染疾病率
  • 全球頭孢菌素藥物市場：市場規模與年複合成長率（2019-2029）
  • COVID-19對頭孢菌素藥物市場的影響
  • 全球頭孢菌素藥物市場區隔：按世代
    • 全球頭孢菌素藥物市場：世代、概述
    • 全球頭孢菌素藥物市場規模：第一代（金額）（2019-2029）
    • 全球頭孢菌素藥物市場規模：第二代（金額）（2019-2029）
    • 全球頭孢菌素藥物市場規模：第三代（金額）（2019-2029）
    • 全球頭孢菌素藥物市場規模：第四代（金額）（2019-2029）
    • 全球頭孢菌素藥物市場規模：第五代（金額）（2019-2029）
  • 全球頭孢菌素藥物市場區隔：依給藥途徑
    • 全球頭孢菌素藥物市場：依給藥途徑概述
    • 全球頭孢菌素藥物市場規模：口服（金額）（2019-2029）
    • 全球頭孢菌素藥物市場規模：注射用（金額）（2019-2029）
  • 全球頭孢菌素藥物市場區隔：依應用
    • 全球頭孢菌素藥物市場：依應用、概述
    • 全球頭孢菌素藥物市場規模：呼吸道感染疾病（金額）（2019-2029）
    • 全球頭孢菌素藥物市場規模：皮膚感染疾病（金額）（2019-2029）
    • 全球頭孢菌素藥物市場規模：尿道感染（金額）（2019-2029）
    • 全球頭孢菌素藥物市場規模：其他（金額）（2019-2029）

第4章 全球頭孢菌素藥物市場、區域分析

  • 研究區域範圍
  • 區域簡介

第5章 美洲頭孢菌素藥物市場：實績與預測（2019-2029）

  • 美洲頭孢菌素藥物市場：概況
  • 美洲頭孢菌素藥物市場：市場規模與年複合成長率（2019-2029）
  • 美洲頭孢菌素藥物市場：主要因素
  • 美洲頭孢菌素藥物市場：細分分析
  • 美洲頭孢菌素藥物市場區隔：按世代
  • 美洲頭孢菌素藥物市場區隔：依給藥途徑
  • 美洲頭孢菌素藥物市場區隔：依應用
  • 美洲頭孢菌素藥物市場區隔：依國家/地區分類
    • 美洲頭孢菌素藥物市場：依國家/地區、概述
    • 美國頭孢菌素藥物市場：市場規模與年複合成長率（2019-2029）
    • 加拿大頭孢菌素藥物市場：市場規模與年複合成長率（2019-2029）
    • 其他美洲頭孢菌素藥物市場：市場規模和年複合成長率（2019-2029）

第6章 歐洲頭孢菌素藥物市場：實績與預測（2019-2029）

  • 歐洲頭孢菌素藥物市場：概況
  • 歐洲頭孢菌素藥物市場：市場規模與年複合成長率（2019-2029）
  • 歐洲頭孢菌素藥物市場：主要因素
  • 歐洲頭孢菌素藥物市場：細分分析
  • 歐洲頭孢菌素藥物市場區隔：按世代
  • 歐洲頭孢菌素藥物市場區隔：依給藥途徑
  • 歐洲頭孢菌素藥物市場區隔：依應用
  • 歐洲頭孢菌素藥物市場區隔：依國家/地區
    • 歐洲頭孢菌素藥物市場：依國家分類，概述
    • 英國頭孢菌素藥物市場：市場規模與年複合成長率（2019-2029）
    • 德國頭孢菌素藥物市場：市場規模與年複合成長率（2019-2029）
    • 法國頭孢菌素藥物市場：市場規模與年複合成長率（2019-2029）
    • 義大利頭孢菌素藥物市場：市場規模與年複合成長率（2019-2029）
    • 其他歐洲頭孢菌素藥物市場：市場規模和年複合成長率（2019-2029）

第7章 亞太地區頭孢菌素藥物市場：實績與預測（2019-2029）

  • 亞太地區頭孢菌素藥物市場：概況
  • 亞太地區頭孢菌素藥物市場：市場規模與年複合成長率（2019-2029）
  • 亞太地區頭孢菌素藥物市場：主要因素
  • 亞太地區頭孢菌素藥物市場：細分分析
  • 亞太地區頭孢菌素藥物市場區隔：按世代
  • 亞太地區頭孢菌素藥物市場區隔：依給藥途徑
  • 亞太地區頭孢菌素藥物市場區隔：依應用
  • 亞太地區頭孢菌素藥物市場區隔：依國家/地區
    • 亞太地區頭孢菌素藥物市場：依國家/地區分類，概述
    • 中國頭孢菌素藥物市場：市場規模及年複合成長率（2019-2029）
    • 日本頭孢菌素藥物市場：市場規模與年複合成長率（2019-2029）
    • 韓國頭孢菌素藥物市場：市場規模與年複合成長率（2019-2029）
    • 印度頭孢菌素藥物市場：市場規模與年複合成長率（2019-2029）
    • 其他亞太地區頭孢菌素藥物市場：市場規模和年複合成長率（2019-2029）

第8章 中東與非洲頭孢菌素藥物市場：實績與預測（2019-2029）

  • 中東和非洲頭孢菌素藥物市場：概況
  • 中東和非洲頭孢菌素藥物市場：市場規模和年複合成長率（2019-2029）
  • 中東和非洲頭孢菌素藥物市場：主要因素
  • 中東和非洲頭孢菌素藥物市場：細分分析
  • 中東和非洲頭孢菌素藥物市場區隔：按世代
  • 中東和非洲頭孢菌素藥物市場區隔：依給藥途徑
  • 中東和非洲頭孢菌素藥物市場區隔：依應用

第9章 市場動態

  • 評估市場動態對全球頭孢菌素藥物市場的影響
  • 促進因素
  • 抑制因素
  • 趨勢

第10章 產業生態系分析

  • 波特五力分析

第11章 競爭定位

  • 企業產品定位
  • 主要企業市場佔有率
  • 公司簡介
    • Lupin Limited
    • Baxter International
    • F. Hoffmann-La Roche AG
    • Eli Lilly and Company
    • Abbott Laboratories
    • Merck & Co., Inc.
    • Novartis
    • Sanofi
    • Pfizer
    • Teva Pharmaceutical

Executive Summary

Azoth Analytics has released a research report titled "Global Cephalosporin Drug Market (2024 Edition)" which provides a complete analysis of the Global Cephalosporin Drug industry in terms of market segmentation By Generation (First Generation, Second Generation, Third Generation, Fourth Generation, Fifth Generation), By Route of Administration (Oral, Parenteral), By Application (Respiratory Tract Infection, Skin Infection, Urinary Tract Infection, Others), By Region (Americas , Europe, Asia-pacific, Middle-East & Africa), for the historical period of 2019-2022, the estimates of 2023 and the forecast period of 2024-2029.

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, United Kingdom, Germany, France, Italy, China, Japan, South Korea, India). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast.

The research report also assesses growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market evolution.

The Global Cephalosporin Drug Market is expected to generate USD 21.9 Billion by the end of 2029, up from USD 13.27 Billion in 2022. A favourable growth element for the global Cephalosporin Drug market is propelled by the prevalence of bacterial infections, antibiotic resistance patterns, regulatory approvals, and the introduction of new formulations. During the forecast period, 2024-2029, Global Cephalosporin Drug is expected to expand at a CAGR of 7.5%. Pharmaceutical companies have focused on developing advanced generations of Cephalosporin drugs to combat bacterial resistance. The development of new generations, combination therapies, extended-release formulations, and expanded indications all contribute to the evolving landscape of Cephalosporin drugs.

The high and growing incidence of bacterial infections worldwide, such as respiratory tract infections, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections, is a significant driving factor. Cephalosporins are commonly prescribed antibiotics for treating these infections, which fuels the demand for Cephalosporin drugs.

The global pharmaceutical supply chains faced disruptions due to lockdowns, transportation restrictions, and factory closures during the pandemic. These disruptions affected the production, distribution, and availability of pharmaceutical products, including Cephalosporin drugs. However, efforts were made to mitigate the impact and ensure a continued supply of essential medications. Also, the pandemic disrupted ongoing clinical trials and delayed the initiation of new trials, including those related to the development of Cephalosporin drugs. This interruption may have impacted the timeline for introducing new Cephalosporins or exploring their expanded uses.

According to the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), Globally, the incidence of Upper Respiratory Infection reached 17*2 billion. Ongoing research involves the development of advanced drug delivery systems, such as inhalable formulations or novel respiratory devices. These technologies aim to enhance the targeted delivery of cephalosporin drugs to the respiratory tract, improving efficacy and minimizing side effects.

Extended-release formulations are designed to release the cephalosporin drug gradually over an extended period, allowing for less frequent dosing. This can lead to improved patient adherence and convenience. Advances in drug delivery technologies, such as controlled-release mechanisms, ensure a sustained therapeutic effect and potentially reduce the risk of side effects associated with rapid drug release.

Continuous manufacturing processes in pharmaceutical production offer advantages in terms of efficiency, cost-effectiveness, and quality control. Applying these processes to cephalosporin production contribute to a more streamlined and scalable manufacturing pipeline. Also, Smart packaging involves incorporating technologies like RFID (Radio-Frequency Identification) or QR codes to monitor drug storage conditions, track expiration dates, and enhance overall product integrity. This ensures the quality and stability of cephalosporin drugs throughout their lifecycle.

Scope of the Report

  • The report analyses the Cephalosporin Drug Market by Value (USD Million).
  • The report presents the analysis of the Cephalosporin Drug Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
  • The report analyses the Cephalosporin Drug Market by Generation (First Generation, Second Generation, Third Generation, Fourth Generation, Fifth Generation).
  • The report analyses the Cephalosporin Drug Market by Route of Administration (Oral, Parenteral).
  • The report analyses the Cephalosporin Drug Market by Application (Respiratory Tract Infection, Skin Infection, Urinary Tract Infection, Others).
  • The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by services, by mode of operation & by end users.
  • Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Lupin Limited, Baxter International, F. Hoffmann-La Roche AG, Eli Lilly and Company, Abbott Laboratories, Merck & Co., Inc., Novartis, Sanofi, Pfizer, Teva Pharmaceutical.

Table of Contents

1. Market Background

  • 1.1 Scope and Product Outlook
  • 1.2 Executive Summary
  • 1.3 Research Methodology

2. Strategic Recommendations

3. Global Cephalosporin Drug Market: Historic and Forecast (2019-2029)

  • 3.1 Impact Analysis of Macro Economic Factors on Global Cephalosporin Drug Market
  • 3.2 Pipeline Scenario
  • 3.3 Global deaths associated with bacterial antimicrobial resistance
  • 3.4 Epidemiology: Global Infectious Disease Prevalence
  • 3.5 Epidemiology: Global Infectious Disease Incidence
  • 3.6 Global Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
  • 3.7 Degree of Impact of Covid-19 on Cephalosporin Drug Market
  • 3.8 Global Cephalosporin Drug Market Segmentation : By Generation
    • 3.8.1 Global Cephalosporin Drug Market, By Generation Overview
    • 3.8.2 Global Cephalosporin Drug Market Size, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.8.3 Global Cephalosporin Drug Market Size, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.8.4 Global Cephalosporin Drug Market Size, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.8.5 Global Cephalosporin Drug Market Size, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.8.6 Global Cephalosporin Drug Market Size, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • 3.9 Global Cephalosporin Drug Market Segmentation : By Route of Administration
    • 3.9.1 Global Cephalosporin Drug Market, By Route of Administration Overview
    • 3.9.2 Global Cephalosporin Drug Market Size, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.9.3 Global Cephalosporin Drug Market Size, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • 3.10 Global Cephalosporin Drug Market Segmentation : By Application
    • 3.10.1 Global Cephalosporin Drug Market, By Application Overview
    • 3.10.2 Global Cephalosporin Drug Market Size, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.10.3 Global Cephalosporin Drug Market Size, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.10.4 Global Cephalosporin Drug Market Size, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 3.10.5 Global Cephalosporin Drug Market Size, By Others, By Value, 2019H-2029F (USD Million & CAGR)

4. Global Cephalosporin Drug Market, Regional Analysis

  • 4.1 Regional Coverage of the Study
  • 4.2 Regional Snapshot

5. Americas Cephalosporin Drug Market: Historic and Forecast (2019-2029)

  • 5.1 Americas Cephalosporin Drug Market: Snapshot
  • 5.2 Americas Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
  • 5.3 Americas Cephalosporin Drug Market: Key Factors
  • 5.4 Americas Cephalosporin Drug Market: Segment Analysis
  • 5.5 Americas Cephalosporin Drug Market Segmentation : By Generation
    • 5.5.1 Americas Cephalosporin Drug Market, By Generation Overview
    • 5.5.2 Americas Cephalosporin Drug Market Size, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.5.3 Americas Cephalosporin Drug Market Size, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.5.4 Americas Cephalosporin Drug Market Size, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.5.5 Americas Cephalosporin Drug Market Size, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.5.6 Americas Cephalosporin Drug Market Size, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • 5.6 Americas Cephalosporin Drug Market Segmentation : By Route of Administration
    • 5.6.1 Americas Cephalosporin Drug Market, By Route of Administration Overview
    • 5.6.2 Americas Cephalosporin Drug Market Size, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.6.3 Americas Cephalosporin Drug Market Size, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • 5.7 Americas Cephalosporin Drug Market Segmentation : By Application
    • 5.7.1 Americas Cephalosporin Drug Market, By Application Overview
    • 5.7.2 Americas Cephalosporin Drug Market Size, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.7.3 Americas Cephalosporin Drug Market Size, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.7.4 Americas Cephalosporin Drug Market Size, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 5.7.5 Americas Cephalosporin Drug Market Size, By Others, By Value, 2019H-2029F (USD Million & CAGR)
  • 5.8 Americas Cephalosporin Drug Market Segmentation : By Country
    • 5.8.1 Americas Cephalosporin Drug Market, By Country Overview
    • 5.8.2 United States Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 5.8.2.1 United States Cephalosporin Drug Market, By Generation
      • 5.8.2.2 United States Cephalosporin Drug Market, By Route of Administration
      • 5.8.2.3 United States Cephalosporin Drug Market, By Application
    • 5.8.3 Canada Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 5.8.3.1 Canada Cephalosporin Drug Market, By Generation
      • 5.8.3.2 Canada Cephalosporin Drug Market, By Route of Administration
      • 5.8.3.3 Canada Cephalosporin Drug Market, By Application
    • 5.10.4 Rest of Americas Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 5.10.4.1 Rest of Americas Cephalosporin Drug Market, By Generation
      • 5.10.4.2 Rest of Americas Cephalosporin Drug Market, By Route of Administration
      • 5.10.4.3 Rest of Americas Cephalosporin Drug Market, By Application

6. Europe Cephalosporin Drug Market: Historic and Forecast (2019-2029)

  • 6.1 Europe Cephalosporin Drug Market: Snapshot
  • 6.2 Europe Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
  • 6.3 Europe Cephalosporin Drug Market: Key Factors
  • 6.4 Europe Cephalosporin Drug Market: Segment Analysis
  • 6.5 Europe Cephalosporin Drug Market Segmentation : By Generation
    • 6.5.1 Europe Cephalosporin Drug Market, By Generation Overview
    • 6.5.2 Europe Cephalosporin Drug Market Size, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.5.3 Europe Cephalosporin Drug Market Size, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.5.4 Europe Cephalosporin Drug Market Size, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.5.5 Europe Cephalosporin Drug Market Size, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.5.6 Europe Cephalosporin Drug Market Size, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • 6.6 Europe Cephalosporin Drug Market Segmentation : By Route of Administration
    • 6.6.1 Europe Cephalosporin Drug Market, By Route of Administration Overview
    • 6.6.2 Europe Cephalosporin Drug Market Size, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.6.3 Europe Cephalosporin Drug Market Size, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • 6.7 Europe Cephalosporin Drug Market Segmentation : By Application
    • 6.7.1 Europe Cephalosporin Drug Market, By Application Overview
    • 6.5.2 Europe Cephalosporin Drug Market Size, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.5.3 Europe Cephalosporin Drug Market Size, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.5.4 Europe Cephalosporin Drug Market Size, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 6.7.5 Europe Cephalosporin Drug Market Size, By Others, By Value, 2019H-2029F (USD Million & CAGR)
  • 6.8 Europe Cephalosporin Drug Market Segmentation : By Country
    • 6.8.1 Europe Cephalosporin Drug Market, By Country Overview
    • 6.8.2 United Kingdom Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 6.8.2.1 United Kingdom Cephalosporin Drug Market, By Generation
      • 6.8.2.2 United Kingdom Cephalosporin Drug Market, By Route of Administration
      • 6.8.2.3 United Kingdom Cephalosporin Drug Market, By Application
    • 6.8.3 Germany Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 6.8.3.1 Germany Cephalosporin Drug Market, By Generation
      • 6.8.3.2 Germany Cephalosporin Drug Market, By Route of Administration
      • 6.8.3.3 Germany Cephalosporin Drug Market, By Application
    • 6.8.4 France Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 6.8.4.1 France Cephalosporin Drug Market, By Generation
      • 6.8.4.2 France Cephalosporin Drug Market, By Route of Administration
      • 6.8.4.3 France Cephalosporin Drug Market, By Application
    • 6.8.5 Italy Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 6.8.5.1 Italy Cephalosporin Drug Market, By Generation
      • 6.8.5.2 Italy Cephalosporin Drug Market, By Route of Administration
      • 6.8.5.3 Italy Cephalosporin Drug Market, By Application
    • 6.8.6 Rest of Europe Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 6.8.6.1 Rest of Europe Cephalosporin Drug Market, By Generation
      • 6.8.6.2 Rest of Europe Cephalosporin Drug Market, By Route of Administration
      • 6.8.6.3 Rest of Europe Cephalosporin Drug Market, By Application

7. Asia Pacific Cephalosporin Drug Market: Historic and Forecast (2019-2029)

  • 7.1 Asia Pacific Cephalosporin Drug Market: Snapshot
  • 7.2 Asia Pacific Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
  • 7.3 Asia Pacific Cephalosporin Drug Market: Key Factors
  • 7.4 Asia Pacific Cephalosporin Drug Market: Segment Analysis
  • 7.5 Asia Pacific Cephalosporin Drug Market Segmentation : By Generation
    • 7.5.1 Asia Pacific Cephalosporin Drug Market, By Generation Overview
    • 7.5.2 Asia Pacific Cephalosporin Drug Market Size, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.5.3 Asia Pacific Cephalosporin Drug Market Size, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.5.4 Asia Pacific Cephalosporin Drug Market Size, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.5.5 Asia Pacific Cephalosporin Drug Market Size, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.5.6 Asia Pacific Cephalosporin Drug Market Size, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • 7.6 Asia Pacific Cephalosporin Drug Market Segmentation : By Route of Administration
    • 7.6.1 Asia Pacific Cephalosporin Drug Market, By Route of Administration Overview
    • 7.6.2 Asia Pacific Cephalosporin Drug Market Size, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.6.3 Asia Pacific Cephalosporin Drug Market Size, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • 7.7 Asia Pacific Cephalosporin Drug Market Segmentation : By Application
    • 7.7.1 Asia Pacific Cephalosporin Drug Market, By ApplicationOverview
    • 7.7.2 Asia Pacific Cephalosporin Drug Market Size, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.7.3 Asia Pacific Cephalosporin Drug Market Size, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.7.4 Asia Pacific Cephalosporin Drug Market Size, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 7.7.5 Asia Pacific Cephalosporin Drug Market Size, By Others, By Value, 2019H-2029F (USD Million & CAGR)
  • 7.8 Asia Pacific Cephalosporin Drug Market Segmentation : By Country
    • 7.8.1 Asia Pacific Cephalosporin Drug Market, By Country Overview
    • 7.8.2 China Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 7.8.2.1 China Cephalosporin Drug Market, By Generation
      • 7.8.2.2 China Cephalosporin Drug Market, By Route of Administration
      • 7.8.2.3 China Cephalosporin Drug Market, By Application
    • 7.8.3 Japan Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 7.8.3.1 Japan Cephalosporin Drug Market, By Generation
      • 7.8.3.2 Japan Cephalosporin Drug Market, By Route of Administration
      • 7.8.3.3 Japan Cephalosporin Drug Market, By Application
    • 7.8.4 South Korea Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 7.8.4.1 South Korea Cephalosporin Drug Market, By Generation
      • 7.8.4.2 South Korea Cephalosporin Drug Market, By Route of Administration
      • 7.8.4.3 South Korea Cephalosporin Drug Market, By Application
    • 7.8.5 India Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 7.8.5.1 India Cephalosporin Drug Market, By Generation
      • 7.8.5.2 India Cephalosporin Drug Market, By Route of Administration
      • 7.8.5.3 India Cephalosporin Drug Market, By Application
    • 7.8.6 Rest of Asia Pacific Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
      • 7.8.6.1 Rest of Asia Pacific Cephalosporin Drug Market, By Generation
      • 7.8.6.2 Rest of Asia Pacific Cephalosporin Drug Market, By Route of Administration
      • 7.8.6.3 Rest of Asia Pacific Cephalosporin Drug Market, By Application

8. Middle East and Africa Cephalosporin Drug Market: Historic and Forecast (2019-2029)

  • 8.1 Middle East and Africa Cephalosporin Drug Market: Snapshot
  • 8.2 Middle East and Africa Cephalosporin Drug Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)
  • 8.3 Middle East and Africa Cephalosporin Drug Market: Key Factors
  • 8.4 Middle East and Africa Cephalosporin Drug Market: Segment Analysis
  • 8.5 Middle East and Africa Cephalosporin Drug Market Segmentation : By Generation
    • 8.5.1 Middle East and Africa Cephalosporin Drug Market, By Generation Overview
    • 8.5.2 Middle East and Africa Cephalosporin Drug Market Size, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.5.3 Middle East and Africa Cephalosporin Drug Market, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.5.4 Middle East and Africa Cephalosporin Drug Market Size, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.5.5 Middle East and Africa Cephalosporin Drug Market, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.5.6 Middle East and Africa Cephalosporin Drug Market, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • 8.6 Middle East and Africa Cephalosporin Drug Market Segmentation : By Route of Administration
    • 8.6.1 Middle East and Africa Cephalosporin Drug Market, By Route of Administration Overview
    • 8.6.2 Middle East and Africa Cephalosporin Drug Market Size, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.6.3 Middle East and Africa Cephalosporin Drug Market Size, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • 8.7 Middle East and Africa Cephalosporin Drug Market Segmentation : By Application
    • 8.7.1 Middle East and Africa Cephalosporin Drug Market, By Application Overview
    • 8.7.2 Middle East and Africa Cephalosporin Drug Market Size, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.7.3 Middle East and Africa Cephalosporin Drug Market Size, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.7.4 Middle East and Africa Cephalosporin Drug Market Size, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
    • 8.7.5 Middle East and Africa Cephalosporin Drug Market, By Others, By Value, 2019H-2029F (USD Million & CAGR)

9. Market Dynamics

  • 9.1 Impact Assessment of Market Dynamics on the Global Cephalosporin Drug Market
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Trends

10. Industry Ecosystem Analysis

  • 10.1 Porter's Five Forces Analysis

11. Competitive Positioning

  • 11.1 Companies' Product Positioning
  • 11.2 Market Share of Leading Companies
  • 11.3 Company Profiling
    • 11.3.1 Lupin Limited
    • 11.3.2 Baxter International
    • 11.4.3 F. Hoffmann-La Roche AG
    • 11.3.4 Eli Lilly and Company
    • 11.3.5 Abbott Laboratories
    • 11.3.6 Merck & Co., Inc.
    • 11.3.7 Novartis
    • 11.3.8 Sanofi
    • 11.3.9 Pfizer
    • 11.3.10 Teva Pharmaceutical

List of Figures

List of Figures

  • Figure 1: Global deaths associated with bacterial antimicrobial resistance by infectious syndrome, 2019
  • Figure 2: Global Cephalosporin Drug Market Size, By Value, 2019-2022 (USD Million)
  • Figure 3: Global Cephalosporin Drug Market Size, By Value, 2023-2029 (USD Million)
  • Figure 4: Global Cephalosporin Drug Market Share, By Generation, 2022 (%)
  • Figure 5: Global Cephalosporin Drug Market Size, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 6: Global Cephalosporin Drug Market Absolute Opportunity, By First Generation, 2019H-2029F (USD Million)
  • Figure 7: Global Cephalosporin Drug Market Size, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 8: Global Cephalosporin Drug Market Absolute Opportunity, By Second Generation, 2019H-2029F (USD Million)
  • Figure 9: Global Cephalosporin Drug Market Size, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 10: Global Cephalosporin Drug Market Absolute Opportunity, By Third Generation, 2019H-2029F (USD Million)
  • Figure 11: Global Cephalosporin Drug Market Size, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 12: Global Cephalosporin Drug Market Absolute Opportunity, By Fourth Generation, 2019H-2029F (USD Million)
  • Figure 13: Global Cephalosporin Drug Market Size, By Fifth Generation , By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 14: Global Cephalosporin Drug Market Absolute Opportunity, By Fifth Generation, 2019H-2029F (USD Million)
  • Figure 15: Global Cephalosporin Drug Market Size, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 16: Global Cephalosporin Drug Market Absolute Opportunity, By Oral, 2019H-2029F (USD Million)
  • Figure 17: Global Cephalosporin Drug Market Size, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 18: Global Cephalosporin Drug Market Absolute Opportunity, By Parenteral, 2019H-2029F (USD Million)
  • Figure 19: Global Cephalosporin Drug Market Size, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 20: Global Cephalosporin Drug Market Absolute Opportunity, By Respiratory Tract Infection, 2019H-2029F (USD Million)
  • Figure 21: Global Cephalosporin Drug Market Size, By Skin Infection , By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 22: Global Cephalosporin Drug Market Absolute Opportunity, By Skin Infection , 2019H-2029F (USD Million)
  • Figure 23: Global Cephalosporin Drug Market Size, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 24: Global Cephalosporin Drug Market Absolute Opportunity, By Urinary Tract Infection, 2019H-2029F (USD Million)
  • Figure 25: Global Cephalosporin Drug Market Size, By Others, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 26: Global Cephalosporin Drug Market Absolute Opportunity, By Others, 2019H-2029F (USD Million)
  • Figure 27: Americas Cephalosporin Drug Market Size, By Value, 2019H-2029F (USD Million)
  • Figure 28: Americas Cephalosporin Drug Market Share, By Generation, 2022 (%)
  • Figure 29: Americas Cephalosporin Drug Market, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 30: Americas Cephalosporin Drug Market, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 31: Americas Cephalosporin Drug Market, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 32: Americas Cephalosporin Drug Market, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 33: Americas Cephalosporin Drug Market, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 34: Americas Cephalosporin Drug Market, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 35: Americas Cephalosporin Drug Market, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 36: Americas Cephalosporin Drug Market, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 37: Americas Cephalosporin Drug Market, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 38: Americas Cephalosporin Drug Market, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 39: Americas Cephalosporin Drug Market, By Others, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 40: United States Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 41: United States Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 42: United States Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 43: United States Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 44: United States Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 45: Canada Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 46: Canada Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 47: Canada Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 48: Canada Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 49: Canada Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 50: Rest of Americas Cephalosporin Drug Market , By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 51: Rest of Americas Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 52: Rest of Americas Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 53: Rest of Americas Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 54: Rest of Americas Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 55: Europe Cephalosporin Drug Market Size, By Value, 2019H-2029F (USD Million)
  • Figure 56: Europe Cephalosporin Drug Market Share, By Generation, 2022 (%)
  • Figure 57: Europe Cephalosporin Drug Market, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 58: Europe Cephalosporin Drug Market, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 59: Europe Cephalosporin Drug Market, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 60: Europe Cephalosporin Drug Market, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 61: Europe Cephalosporin Drug Market, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 62: Europe Cephalosporin Drug Market, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 63: Europe Cephalosporin Drug Market, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 64: Europe Cephalosporin Drug Market, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 65: Europe Cephalosporin Drug Market, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 66: Europe Cephalosporin Drug Market, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 67: Europe Cephalosporin Drug Market, By Others, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 68: United Kingdom Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 69: United Kingdom Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 70: United Kingdom Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 71: United Kingdom Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 72: United Kingdom Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 73: Germany Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 74: Germany Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 75: Germany Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 76: Germany Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 77: Germany Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 78: France Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 79: France Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 80: France Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 81: France Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 82: France Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 83: Italy Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 84: Italy Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 85: Italy Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 86: Italy Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 87: Italy Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 88: Rest of Europe Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 89: Rest of Europe Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 90: Rest of Europe Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 91: Rest of Europe Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 92: Rest of Europe Cephalosporin Drug MarketShare, By Application, By Value, 2022 (%)
  • Figure 93: Asia-Pacific Cephalosporin Drug Market Size, By Value, 2019H-2029F (USD Million)
  • Figure 94: Asia-Pacific Cephalosporin Drug Market Share, By Generation, 2022 (%)
  • Figure 95: Asia-Pacific Cephalosporin Drug Market, By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 96: Asia-Pacific Cephalosporin Drug Market, By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 97: Asia-Pacific Cephalosporin Drug Market, By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 98: Asia-Pacific Cephalosporin Drug Market, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 99: Asia-Pacific Cephalosporin Drug Market, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 100: Asia-Pacific Cephalosporin Drug Market, By Oral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 101: Asia-Pacific Cephalosporin Drug Market, By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 102: Asia-Pacific Cephalosporin Drug Market, By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 103: Asia-Pacific Cephalosporin Drug Market, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 104: Asia-Pacific Cephalosporin Drug Market, By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 105: Asia-Pacific Cephalosporin Drug Market, By Others, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 106: China Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 107: China Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 108: China Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 109: China Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 110: China Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 111: Japan Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 112: Japan Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 113: Japan Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 114: Japan Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 115: Japan Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 116: South Korea Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 117: South Korea Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 118: South Korea Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 119: South Korea Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 120: South Korea Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 121: India Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 122: India Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 123: India Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 124: India Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 125: India Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 126: Rest of Asia-Pacific Cephalosporin Drug Market, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 127: Rest of Asia-Pacific Cephalosporin Drug Market Value, By Application, 2022 (USD Million)
  • Figure 128: Rest of Asia-Pacific Cephalosporin Drug Market Share, By Generation, By Value, 2022 (%)
  • Figure 129: Rest of Asia-Pacific Cephalosporin Drug Market Share, By Route of Administration, By Value, 2022 (%)
  • Figure 130: Rest of Asia-Pacific Cephalosporin Drug Market Share, By Application, By Value, 2022 (%)
  • Figure 131: Middle East and Africa Cephalosporin Drug Market Size, By Value, 2019H-2029F (USD Million)
  • Figure 132: Middle East and Africa Cephalosporin Drug Market Share, By Generation, 2022 (%)
  • Figure 133: Middle East and Africa Cephalosporin Drug Market , By First Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 134: Middle East and Africa Cephalosporin Drug Market , By Second Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 135: Middle East and Africa Cephalosporin Drug Market , By Third Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 136: Middle East and Africa Cephalosporin Drug Market, By Fourth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 137: Middle East and Africa Cephalosporin Drug Market, By Fifth Generation, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 138: Middle East and Africa Cephalosporin Drug Market , By Oral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 139: Middle East and Africa Cephalosporin Drug Market , By Parenteral, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 140: Middle East and Africa Cephalosporin Drug Market , By Respiratory Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 141: Middle East and Africa Cephalosporin Drug Market, By Skin Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 142: Middle East and Africa Cephalosporin Drug Market , By Urinary Tract Infection, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 143: Middle East and Africa Cephalosporin Drug Market , By Others, By Value, 2019H-2029F (USD Million & CAGR)
  • Figure 144: Global Impact of Drivers and Restraints
  • Figure 145: Market Share of Prominent Companies of Cephalosporin Drug, 2022 (%)
  • Figure 146: Lupin Revenues, 2020-2022 (USD Million)
  • Figure 147: Lupin Revenues, By Geographic Segments, 2022 (%)
  • Figure 148: Lupin Revenue , By Business Segments, 2022 (%)
  • Figure 149: Baxter International Revenues, 2020-2022 (USD Million)
  • Figure 150: Baxter International Revenues, By Geographic Segments, 2022 (%)
  • Figure 151: Baxter International Revenue , By Business Segments, 2022 (%)
  • Figure 152: Roche Revenues, 2020-2022 (USD Million)
  • Figure 153: Roche Revenue , By Business Segment, 2022 (%)
  • Figure 154: Eli Lilly and Company Revenues, 2020-2022 (USD Million)
  • Figure 155: Eli Lilly and Company Revenues, By Geographic Segments, 2022 (%)
  • Figure 156: Eli Lilly and Company Revenue , By Therapeutic Area, 2022 (%)
  • Figure 157: Abbott Laboratories Revenues, 2020-2022 (USD Million)
  • Figure 158: Abbott Laboratories Revenues, By Geographic Segments, 2022 (%)
  • Figure 159: Abbott Laboratories Revenue , By Business Segments, 2022 (%)
  • Figure 160: Merck & Co., Inc. Revenues, 2020-2022 (USD Million)
  • Figure 161: Merck & Co., Inc. Revenues, By Geographic Segments, 2022 (%)
  • Figure 162: Merck & Co., Inc. Revenue , By Business Segments, 2022 (%)
  • Figure 163: Novartis Revenues, 2020-2022 (USD Million)
  • Figure 164: Novartis Revenue , By Business Segments, 2022 (%)
  • Figure 165: Novartis Revenue , By Geographical Segments, 2022 (%)
  • Figure 166: Sanofi Revenues, 2020-2022 (USD Million)
  • Figure 167: Sanofi Revenues, By Geographic Segments, 2022 (%)
  • Figure 168: Sanofi Revenue , By Business Segments, 2022 (%)
  • Figure 169: Pfizer Revenues, 2020-2022 (USD Million)
  • Figure 170: Pfizer Revenues, By Business Segments, 2022 (%)
  • Figure 171: Pfizer Inc. Revenue , By Geographical Segments, 2022 (%)
  • Figure 172: Teva Pharmaceuticals Revenues, 2020-2022 (USD Million)
  • Figure 173: Teva Pharmaceuticals Revenue , By Geographical Segments, 2022 (%)

List of Tables

Table A1: Global Impact of Macro Economic Factors, By Region

Table A2: Cephalosporin Drug in Pipeline

Table A3: United States Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A4: United States Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A5: United States Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A6: United States Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A7: United States Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A8: United States Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A9: Canada Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A10: Canada Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A11: Canada Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A12: Canada Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A13: Canada Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A14: Canada Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A15: Rest of Americas Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A16: Rest of Americas Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A17: Rest of Americas Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A18: Rest of Americas Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A19: Rest of Americas Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A20: Rest of Americas Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A21: United Kingdom Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A22: United Kingdom Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A23: United Kingdom Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A24: United Kingdom Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A25: United Kingdom Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A26: United Kingdom Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A27: Germany Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A28: Germany Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A29: Germany Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A30: Germany Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A31: Germany Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A32: Germany Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A33: France Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A34: France Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A35: France Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A36: France Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A37: France Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A38: France Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A39: Italy Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A40: Italy Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A41: Italy Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A42: Italy Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A43: Italy Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A44: Italy Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A45: Rest of Europe Cephalosporin Drug Market , By Generation, By Value, 2019-2022 (USD Million)

Table A46: Rest of Europe Cephalosporin Drug Market , By Generation, By Value, 2023-2029 (USD Million)

Table A47: Rest of Europe Cephalosporin Drug Market , By Route of Administration, By Value, 2019-2022 (USD Million)

Table A48: Rest of Europe Cephalosporin Drug Market , By Route of Administration, By Value, 2023-2029 (USD Million)

Table A49: Rest of Europe Cephalosporin Drug Market , By Application, By Value, 2019-2022 (USD Million)

Table A50: Rest of Europe Cephalosporin Drug Market , By Application, By Value, 2023-2029 (USD Million)

Table A51: China Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A52: China Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A53: China Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A54: China Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A55: China Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A56: China Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A57: Japan Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A58: Japan Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A59: Japan Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A60: Japan Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A61: Japan Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A62: Japan Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A63: South Korea Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A64: South Korea Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A65: South Korea Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A66: South Korea Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A67: South Korea Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A68: South Korea Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A69: India Cephalosporin Drug Market, By Generation, By Value, 2019-2022 (USD Million)

Table A70: India Cephalosporin Drug Market, By Generation, By Value, 2023-2029 (USD Million)

Table A71: India Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A72: India Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A73: India Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A74: India Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A75: Rest of Asia-Pacific Cephalosporin Drug Market, By Generation Industry, By Value, 2019-2022 (USD Million)

Table A76: Rest of Asia-Pacific Cephalosporin Drug Market, By Generation Industry, By Value, 2023-2029 (USD Million)

Table A77: Rest of Asia-Pacific Cephalosporin Drug Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A78: Rest of Asia-Pacific Cephalosporin Drug Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A79: Rest of Asia-Pacific Cephalosporin Drug Market, By Application, By Value, 2019-2022 (USD Million)

Table A80: Rest of Asia-Pacific Cephalosporin Drug Market, By Application, By Value, 2023-2029 (USD Million)

Table A81: Lupin Key Financials, 2020-2022

Table A82: Baxter International Key Financials, 2020-2022

Table A83: Roche Key Financials, 2020-2022

Table A84: Eli Lilly and Company Key Financials, 2020-2022

Table A85: Abbott Laboratories Key Financials, 2020-2022

Table A86: Merck & Co., Inc. Key Financials, 2020-2022

Table A87: Novartis Key Company Financials, 2020-2022

Table A88: Sanofi Key Financials, 2020-2022

Table A89: Pfizer Key Financials, 2020-2022

Table A90: Teva Pharmaceuticals Key Company Financials, 2020-2022